Cercano Management LLC Neurocrine Biosciences Inc Transaction History
Cercano Management LLC
- $3.78 Billion
- Q4 2024
A detailed history of Cercano Management LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Cercano Management LLC holds 24,000 shares of NBIX stock, worth $2.8 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
24,000Holding current value
$2.8 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding NBIX
# of Institutions
650Shares Held
96.2MCall Options Held
380KPut Options Held
382K-
Black Rock Inc. New York, NY14.2MShares$1.66 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.18 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$572 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$353 Million0.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.49MShares$291 Million0.54% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...